Skip to main content

Table 2 Prevalence of G6PD deficiency in Venezuelan individuals from Sifontes and Cajigal municipalities and G6PD gene alleles from subjects with biochemical deficiency

From: Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-202A/376G variant

Geographical setting

Gender

TOTAL

G6PD determination results

Biochemical test*

DNA analysis(**)

Normal(a)

G6PDd(#, b)

Wild-type allele

202G → A allele

376A → G allele

Cajigal municipality (Sucre state) n = 332

F

163

156 (95.7)

7 (4.3)

3

4

4

M

169

156 (92.3)

13 (7.7)

1

11

12

Sifontes municipality (Bolívar state) n = 332

F

164

163 (99.4)

1 (0.6)

1

0

0

M

168

165 (98.2)

3 (1.8)

0

2

3

  

664

640 (96.4)

24 (3.6)

5 (20.8)

17 (70.8)

19 (79.2)

  1. Data are in number (percentage) of cases for each condition
  2. F females, M males, G6PDd G6PD-deficient subjects
  3. # p = 0.001 by Fisher’s exact test for the comparison of G6PD deficiency prevalence among subjects of Cajigal vs. Sifontes municipality
  4. * The biochemical test used was a NeoLiSA G6PD assay (Interscientific®, Hollywood, USA). p < 0.0001 by Student’s test for comparison of mean G6PD enzyme activity among normal and G6PDd subjects
  5. ** DNA analysis by PCR/RFLP and sequencing of the exons 4–8 of G6PD gene from subjects with biochemical deficiency. The other alleles, which were studied by sequencing (185C → A, 542A → T, 592C → T, 593G → C, 634A → G, 637G → T, 680G → A, 820G → A, 835A → T, 854G → A and 871G → A) resulted wild-type
  6. aMean G6PD enzyme activity of 12.9 ± 3.8 U/g Hb [defined as Class IV (in 84 %) and V (in 2 %) (data not shown)], according to WHO criteria (33, 34)
  7. bMean G6PD enzyme activity of 4.5 ± 1.2 U/g Hb (defined as moderately deficient enzyme, Class III, according to WHO criteria [33, 34]. p = 0.007 among G6PDd males and females compared by Student’s test